Guardian molecule keeps cells on track: New perspectives for the treatment of liver cancer
A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...
Precision gene therapy for liver disorders increases number of correctly repaired cells
Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...
precisionmedicineonline17h
FDA Clears Lion TCR to Begin Phase II Trial of TCR T-Cell Therapy in HBV-Related Liver Cancer
The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.
A Promising Development for Millions of People With Liver Disease
Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.
Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services
Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) and its oncology-focused subsidiary, Citius ...